Hippo/YAP signaling pathway has been recognized as a linchpin in cancer therapy; dysregulation of core components (MST1/2, LATS1/2, YAP, etc.)associates with initiation, migration, invasion as well as therapeutic resistance of various types of cancer [25]. The gene discussed is MST1; the disease is cancer.